Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    Levopraid

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 92Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Icrom
    Italy
    		 Taegeuk Pharmaceutical Co., Ltd. 20110812-124-H-58-01(2) Sulpiride 2012-07-27 ICROM SpA Italy Via Delle Arti 33 (via Primo Maggio 36 secondary gate)20049 Concorezzo, Milan
    29/11/2025 Icrom
    Italy
    		 Myungin Pharmaceutical Co., Ltd. 20110812-124-H-58-01(1) Sulpiride 2011-09-02 ICROM Srl Italy Via Delle Arti 33, 20863 Concorezzo, MB